Latest week
10 Jul 2026
Close
187.000000
Fair value
170.850538
Next-week expectancy
Positive 71.53%
Sharemaestro

GALD Chart Pack

Galderma Group AG

Exchange
VIE
Latest week
10 Jul 2026
Close
187.000000
Fair value
170.850538
Next-week expectancy
Positive 71.53%
Generated
17 Jul 2026 17:29
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, GALD rose 6.25%, moving from 176.00 to 187.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Market Dynamics is 1.11 on the latest week. Next-week expectancy is positive at 71.53% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
187.00
12-Week Change
6.25%
Trend Signal
Active
Next-Week Expectancy
Positive 71.53%
Signal Weeks
9 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Market Dynamics
1.11

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
187.00
12-Week Change
6.25%
Trend Signal
Active
Next-Week Expectancy
Positive 71.53%
Signal Weeks
9 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Market Dynamics
1.11

Over the latest 12 completed weeks ending 2026-07-10, GALD rose 6.25%, moving from 176.00 to 187.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Market Dynamics is 1.11 on the latest week. Next-week expectancy is positive at 71.53% based on similar historical setup states.

Industry Peers

Austria equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
ZOTS Zoetis Inc. VIE 10 Jul 2026 66.24 67.08 64.46 66.98 1.12%
KRKG Krka, d. d. VIE 10 Jul 2026 262.50 265.50 260.50 263.00 0.19%
GHC Gallmetzer HealthCare SPA VIE 10 Jul 2026 3.60 3.60 3.60 3.60 0.00%
LUNB H. Lundbeck A/S VIE 10 Jul 2026 5.76 5.85 5.69 5.69 -1.13%
ALM Almirall, S.A. VIE 10 Jul 2026 11.42 11.76 11.28 11.28 -1.23%
ROVI Laboratorios Farmaceuticos Rovi, S.A. VIE 10 Jul 2026 57.00 57.65 55.95 55.95 -1.84%
LUNA H. Lundbeck A/S VIE 10 Jul 2026 4.96 4.97 4.84 4.87 -1.92%
TKD Takeda Pharmaceutical Company Limited VIE 10 Jul 2026 29.68 29.82 28.85 28.85 -2.80%
DMP Dermapharm Holding SE VIE 10 Jul 2026 47.65 47.65 45.65 45.75 -3.99%
TLR2 Tilray Brands, Inc. VIE 10 Jul 2026 4.07 4.10 3.72 3.90 -4.18%
MRCK Merck KGaA VIE 10 Jul 2026 146.70 146.70 138.15 140.15 -4.46%
TEVA Teva Pharmaceutical Industries Limited VIE 10 Jul 2026 30.40 31.10 28.60 29.00 -4.61%
EVT Evotec SE VIE 10 Jul 2026 5.17 5.19 4.85 4.92 -4.74%
IPN Ipsen S.A. VIE 10 Jul 2026 171.40 172.40 162.00 162.00 -5.48%
SDZ Sandoz Group AG VIE 10 Jul 2026 78.82 78.82 73.48 73.52 -6.72%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.